| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.539 | 44.372 | 38.540 | 44.798 | 42.961 | 36.672 | 47.813 | 46.173 | 56.965 | 193.012 |
| Total Income - EUR | 37.545 | 44.378 | 38.544 | 45.665 | 42.966 | 36.677 | 47.817 | 46.177 | 58.395 | 193.639 |
| Total Expenses - EUR | 28.033 | 39.062 | 33.361 | 29.861 | 29.938 | 26.777 | 32.829 | 35.130 | 56.407 | 91.850 |
| Gross Profit/Loss - EUR | 9.512 | 5.316 | 5.183 | 15.804 | 13.028 | 9.900 | 14.988 | 11.047 | 1.988 | 101.789 |
| Net Profit/Loss - EUR | 8.386 | 4.428 | 4.798 | 15.348 | 12.599 | 9.651 | 14.646 | 10.654 | 1.480 | 96.288 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 5 |
Check the financial reports for the company - Ginemed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21.089 | 17.526 | 22.475 | 21.440 | 20.414 | 19.428 | 24.249 | 22.981 | 41.760 | 39.695 |
| Current Assets | 50.441 | 19.643 | 20.886 | 30.714 | 36.212 | 42.326 | 41.630 | 54.778 | 37.658 | 137.766 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.271 | 1.089 | 2.131 | 1.507 | 1.478 | 0 | 1.839 | 2.229 | 5.253 | 691 |
| Cash | 49.170 | 18.554 | 18.756 | 29.207 | 34.734 | 42.326 | 39.791 | 52.549 | 32.405 | 116.971 |
| Shareholders Funds | 34.741 | 30.514 | 36.643 | 46.609 | 53.142 | 56.266 | 64.088 | 74.941 | 76.194 | 170.584 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 36.790 | 6.655 | 6.719 | 6.293 | 4.218 | 5.489 | 1.791 | 2.817 | 3.224 | 6.877 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ginemed S.r.l.